WO2009062497A3 - Verfahren zur endtiterbestimmung und dessen auswertung mittels indirekten immunfluoreszenz test - Google Patents

Verfahren zur endtiterbestimmung und dessen auswertung mittels indirekten immunfluoreszenz test Download PDF

Info

Publication number
WO2009062497A3
WO2009062497A3 PCT/DE2008/001894 DE2008001894W WO2009062497A3 WO 2009062497 A3 WO2009062497 A3 WO 2009062497A3 DE 2008001894 W DE2008001894 W DE 2008001894W WO 2009062497 A3 WO2009062497 A3 WO 2009062497A3
Authority
WO
WIPO (PCT)
Prior art keywords
indirect immunofluorescence
immunofluorescence assay
evaluation
determination
titre
Prior art date
Application number
PCT/DE2008/001894
Other languages
English (en)
French (fr)
Other versions
WO2009062497A2 (de
Inventor
Rico Hiemann
Original Assignee
Medipan Gmbh
Rico Hiemann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipan Gmbh, Rico Hiemann filed Critical Medipan Gmbh
Priority to US12/741,341 priority Critical patent/US20100267168A1/en
Priority to DE112008003644T priority patent/DE112008003644A5/de
Priority to AU2008323375A priority patent/AU2008323375A1/en
Priority to JP2010533432A priority patent/JP2011503586A/ja
Priority to CN200880115751.0A priority patent/CN101874206B/zh
Priority to EP08848943.0A priority patent/EP2208068B1/de
Priority to CA2702421A priority patent/CA2702421C/en
Publication of WO2009062497A2 publication Critical patent/WO2009062497A2/de
Publication of WO2009062497A3 publication Critical patent/WO2009062497A3/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Abstract

Die Erfindung betrifft ein Verfahren zur Endtiterbestimmung bei der Bestimmung von Antikörpern gegen nukleäre und zytoplasmatische Antigene in Humanen Seren mittels indirekten Immunfluoreszenz Test. Die Erfindung betrifft darüber hinaus einen Kit zur in-vitro Diagnostik zur Bestimmung von Antikörpern gegen nukleäre und zytoplasmatische Antigene in Humanen Seren mittels indirekten Immunfluoreszenz Test und ein Computerprogramm zur Auswertung und zur Bestimmung des Endtiters im Rahmen des genannten Verfahrens.
PCT/DE2008/001894 2007-11-13 2008-11-13 Verfahren zur endtiterbestimmung und dessen auswertung mittels indirekten immunfluoreszenz test WO2009062497A2 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US12/741,341 US20100267168A1 (en) 2007-11-13 2008-11-13 Method for end titre determination and the evaluation thereof by means of an indirect immunoflurescence assay
DE112008003644T DE112008003644A5 (de) 2007-11-13 2008-11-13 Verfahren zur Endtiterbestimmung und dessen Auswertung mittels indirekten Immunfluoreszenz Test
AU2008323375A AU2008323375A1 (en) 2007-11-13 2008-11-13 Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay
JP2010533432A JP2011503586A (ja) 2007-11-13 2008-11-13 間接免疫蛍光測定法による最終抗体価の測定方法およびその評価方法
CN200880115751.0A CN101874206B (zh) 2007-11-13 2008-11-13 通过间接免疫荧光测定的终点效价确定方法及其评估方法
EP08848943.0A EP2208068B1 (de) 2007-11-13 2008-11-13 Verfahren zur endtiterbestimmung und dessen auswertung mittels indirekten immunfluoreszenz test
CA2702421A CA2702421C (en) 2007-11-13 2008-11-13 Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007054792 2007-11-13
DE102007054792.9 2007-11-13

Publications (2)

Publication Number Publication Date
WO2009062497A2 WO2009062497A2 (de) 2009-05-22
WO2009062497A3 true WO2009062497A3 (de) 2009-08-20

Family

ID=40376176

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2008/001894 WO2009062497A2 (de) 2007-11-13 2008-11-13 Verfahren zur endtiterbestimmung und dessen auswertung mittels indirekten immunfluoreszenz test

Country Status (8)

Country Link
US (1) US20100267168A1 (de)
EP (1) EP2208068B1 (de)
JP (1) JP2011503586A (de)
CN (1) CN101874206B (de)
AU (1) AU2008323375A1 (de)
CA (1) CA2702421C (de)
DE (1) DE112008003644A5 (de)
WO (1) WO2009062497A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2362222B1 (de) * 2010-02-22 2013-06-26 Medipan GmbH Verfahren und Vorrichtung zur simultanen Detektion von an synthetische oder zelluläre und/oder Gewebesubstrate gebundenen Antikörpern
CN103460043A (zh) * 2011-01-05 2013-12-18 宙斯科技公司 诊断方法
AU2012266564B2 (en) * 2011-06-06 2013-12-19 Medipan Gmbh Methods and system for the automated determination of immunofluorescent foci using a cell-based immunofluorescence assay using synthetic calibration particles
US20130052662A1 (en) * 2011-08-23 2013-02-28 University Of Medicine And Dentistry Of New Jersey Method for Automated Autoantibody Detection and Identification
CN104115190B (zh) 2011-09-30 2018-06-01 生命技术公司 用于在图像中减去背景的方法和系统
US9495741B2 (en) * 2011-09-30 2016-11-15 Life Technologies Corporation Methods and systems for streamlining optical calibration
CN105814441B (zh) * 2013-12-11 2017-10-03 日本电气株式会社 抗核抗体图像分析系统、抗核抗体图像分析方法和抗核抗体图像分析程序
CN104459159A (zh) * 2014-12-23 2015-03-25 广州南杰生物技术有限公司 一种检测自身免疫肝病相关自身抗体谱的试剂盒
CN106841628A (zh) * 2017-03-02 2017-06-13 广州市康润生物科技有限公司 鼻咽癌精准诊断全自动检测系统
CN106950372A (zh) * 2017-03-02 2017-07-14 广州市康润生物科技有限公司 Eb病毒vca/ea‑iga细胞免疫荧光检测试剂
EP3591406A1 (de) * 2018-07-06 2020-01-08 Euroimmun Medizinische Labordiagnostika AG Vorrichtung und verfahren zur antikörperdetektion
CN109374883B (zh) * 2018-08-27 2022-02-11 北京科跃中楷生物技术有限公司 一种基于细胞爬片的快速经济的免疫荧光方法
US11822067B2 (en) 2019-06-27 2023-11-21 Medipan Gmbh XYZ microscope stage with a vertically translatable carriage
CN111077001B (zh) * 2020-01-12 2022-05-10 天津市宝坻区人民医院 抗血小板抗体生物薄片的制作方法
CN114264808B (zh) * 2021-12-28 2022-09-30 南京岚煜生物科技有限公司 基于抗原检测试剂的抗原中和当量的确定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5528521A (en) * 1994-05-27 1996-06-18 Hoffmann-La Roche Inc. Titration emulation system and method
JPH08304284A (ja) * 1995-05-09 1996-11-22 Suzuki Motor Corp 抗核抗体反応判定装置
JPH09281108A (ja) * 1996-04-08 1997-10-31 Nippon Dpc Corp 光学検査装置
DE19801400C2 (de) * 1998-01-16 2001-10-18 Petra Perner Verfahren zur automatischen Erkennung, Eigenschaftsbeschreibung und Interpretation von Hep-2-Zellmustern
US20030138959A1 (en) * 2002-01-17 2003-07-24 Carter Jesse M. Method of detecting oxidizing adulterants in urine
JP2005091701A (ja) * 2003-09-17 2005-04-07 Matsushita Electric Ind Co Ltd 蛍光顕微鏡及び蛍光顕微鏡の励起光源制御方法
ES2298791T3 (es) * 2004-04-08 2008-05-16 Petra Perner Procedimiento para adquisicion de formas a partir de celulas hep-2 y de reconocimiento por casos de celulas hep-2.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HERR J C ET AL: "AN ELISA FOR MEASURING ANTISPERM AUTOANTIBODIES FOLLOWING VASECTOMY IN LEWIS RATS", AJRIM (AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY AND MICROBIOLOGY), vol. 11, no. 3, 1986, pages 75 - 81, XP008102830, ISSN: 8755-8920 *
HOLLINGSWORTH PETER N ET AL: "Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, vol. 3, no. 4, 1996, pages 374 - 377, XP002517115, ISSN: 1071-412X *

Also Published As

Publication number Publication date
EP2208068A2 (de) 2010-07-21
DE112008003644A5 (de) 2010-10-28
AU2008323375A1 (en) 2009-05-22
WO2009062497A2 (de) 2009-05-22
CA2702421C (en) 2013-03-26
CA2702421A1 (en) 2009-05-22
CN101874206A (zh) 2010-10-27
CN101874206B (zh) 2015-01-07
EP2208068B1 (de) 2013-04-17
JP2011503586A (ja) 2011-01-27
US20100267168A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
WO2009062497A3 (de) Verfahren zur endtiterbestimmung und dessen auswertung mittels indirekten immunfluoreszenz test
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
PH12016500658B1 (en) Human anti-alpha-synuclein autoantibodies
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
WO2007117444A3 (en) Protein detection by aptamers
WO2006117689A3 (en) Method for diagnosing multiple sclerosis
WO2008060394A3 (en) Methods and assays for detecting gp73-specific autoantibodies
ZA201000093B (en) Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies
WO2010090471A3 (ko) 제1형 당뇨병의 신규한 진단 마커
WO2010009987A3 (en) Diagnostic antibody assay
FR2896588B1 (fr) Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3.
PL1904627T3 (pl) Sposób przygotowania wirusa PRRS i jego białek oraz diagnostycznych zestawów testowych przeznaczonych do jego detekcji
WO2010002911A3 (en) Methods and materials for monitoring myeloma using quantitative mass spetrometry
BRPI0410261B8 (pt) anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3
MX344935B (es) Analisis para detectar anticuerpos especificos a anticuerpos anti-ige terapeuticos y su uso en anafilaxis.
WO2009055218A3 (en) Nondestructive inspection of a structure including the analysis of cavity electromagnetic field response
WO2012017466A8 (en) Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof
WO2012100070A3 (en) Methods and apparatus for detection of gluten sensitivity, and its differentiation from celiac disease
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
BR112012033163A2 (pt) ''anticorpos monoclonais, linhagens celulares, usos de um anticorpo, kit, métodos para detectar um anticorpo, composição de anticorpo e uso de uma composição de anticorpo''
WO2011129762A9 (en) Method and kit for cancer diagnosis
CL2012003165A1 (es) Metodo para detectar pared de celulas de levadura en una muestra que comprende exponer dicha muestra a un anticuerpo primario capaz de unirse a un antigeno derivado de glucano; composicion que comprende un derivado de glucano ligado a una proteina; anticuerpo monoclonal capaz de unirse al derivado de glucano; metodo para preparar anticuerpos; kit de deteccion .
WO2006138324A3 (en) Treponema pallidum antigens for vaccine development and diagnostic tests
WO2010053772A3 (en) Disease-associated antigens and methods of use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880115751.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08848943

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008848943

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2702421

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008323375

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 12741341

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2008323375

Country of ref document: AU

Date of ref document: 20081113

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2010533432

Country of ref document: JP

REF Corresponds to

Ref document number: 112008003644

Country of ref document: DE

Date of ref document: 20101028

Kind code of ref document: P